The mucin MUC16 (or CA125) is mostly known as a biomarker in ovarian cancer and is used to monitor patients as an indicator of cancer recurrence (Felder et al., 2014; Haridas et al., 2014; Das and Batra, 2015). The gene discussed is MUC5AC; the disease is ovarian carcinoma.